Hereditary thrombocytopenia with familial novel mutation in MYH9 gene: A familial case report |
| |
Affiliation: | 1. Department of Hematology, Selcuk University, Faculty of Medicine, Konya, Turkey;2. Department of Medical Genetic, Konya City Hospital, Konya, Turkey;3. Department of Pediatric Hematology, Konya City Hospital, Konya, Turkey;4. Department of General Surgery, Konya Numune Hospital, Konya, Turkey;1. Department of Molecular Hematology, Sanquin Research, Amsterdam, The Netherlands;2. Department of Pediatric Hematology, Erasmus MC Sophia Children’s Hospital, University Medical Center Rotterdam, The Netherlands;3. Unit of Transfusion Medicine, Sanquin Blood Supply, Amsterdam, The Netherlands;4. Department of Immunohematology Diagnostic, Sanquin Diagnostic Services, Amsterdam, The Netherlands;5. Department of Human Genetics, Amsterdam University Medical Center, Amsterdam, The Netherlands;6. Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden, The Netherlands;7. Department of Hematology, Erasmus MC, University Medical Center Rotterdam, The Netherlands;8. Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands;9. Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands;10. Center for Clinical Transfusion Research, Sanquin Research, Amsterdam and Landsteiner Laboratory, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands;1. Department of Transfusion Medicine, Government Medical College and Hospital, Chandigarh, India;2. Department of Transfusion Medicine, Maharishi Markandeshwar College of Medical Sciences and Research, Sadopur, Ambala, India;3. Department of Biochemistry, Government Medical College and Hospital, Chandigarh, India;1. Department of Biochemistry, University of Crete Medical School, 71003 Heraklion, Crete, Greece;2. Institute of Molecular Biology and Biotechnology, Foundation for Research and Technology – Hellas, Nikolaou Plastira 100, 70013 Heraklion, Crete, Greece;3. Biomedical Research Foundation, Academy of Athens, Soranou Ephessiou 4, 11527 Athens, Greece;4. Institute of Biosciences and Applications, National Center for Scientific Research “Demokritos”, Patriarchou Grigoriou & Neapoleos 27, 15310, Athens, Greece;5. Division of Biopharmaceutics, Leiden Academic Centre for Drug Research, Einsteinweg 55, 2333 Leiden, the Netherlands;6. Whitaker Cardiovascular Institute, Boston University School of Medicine, Boston MA 02118, USA;1. Department of Hematology and Blood Banking, Faculty of Allied Medicine, Iran University of Medical Sciences, Tehran, Islamic Republic of Iran;2. Iranian Comprehensive Hemophilia Care Center, Tehran, Islamic Republic of Iran;3. Department of Medical Biotechnology, Faculty of Allied Medicine, Iran University of Medical Science, Tehran, Islamic Republic of Iran |
| |
Abstract: | One of the rarest types of hereditary thrombocytopenia is the MYH9-related disorder. This spectrum of disorders is characterized by large platelets with or without leukocyte inclusion bodies, a decrease in the total number of platelets, and autosomal dominant inheritance. Proteinuric nephropathy that frequently progresses to end-stage renal failure, as well as the beginning of progressive high-frequency sensorineural hearing loss in young adults, is also associated with MYH9-related disorder. In this case report, we presented three family members who had thrombocytopenia and in whom a heterozygous novel 22 bp deletion (c.4274_4295del) was detected which is located in exon 31 of the MYH9 gene. There was no evidence of bleeding in the family members we presented and thrombocytopenia was detected incidentally. Additionally, renal failure, hearing loss, presenile cataracts, and clinical symptoms were not detected in these family members. This novel mutation detected in the MYH9 gene has not been reported in the literature before. |
| |
Keywords: | Döhle body Giant platelet Hereditary macrothrombocytopenia Thrombocytopenia |
本文献已被 ScienceDirect 等数据库收录! |
|